June 23, 2026
Overcoming Barriers to Adopting the Four-Month Regimen: A Pathfinding Mission to Improve Access to Newer TB Treatments
A landmark tuberculosis study showed that drug-sensitive TB can be treated in four months instead of six using the WHO-endorsed HPMZ regimen. This factsheet examines barriers to adoption, the role of new fixed-dose combinations, Global Fund GC8 funding opportunities, and advocacy strategies to expand access
June 18, 2026
TAG Statement: OMB Proposal Would Turn Federal Grants Into a Political Tool
The White House Office Of Management and Budget (OMB) under the direction of Russell Vought is seeking a regulatory blessing to use Federal grant funding as a tool for political extortion, violation of due process, and further undermining of scientific integrity. Targets include scientists, institutions, organizations, States, cities, and other…
June 16, 2026
Community and Civil Society Engagement Case Studies
The ASCENT DR-TB project, funded by Unitaid and led by the KNCV Tuberculosis Foundation, aims to improve access to shorter, safer and more effective treatment regimens for drug-resistant TB (DR-TB) and comprehensive, person-centered packages of quality care.
June 16, 2026
The Cure Hep C Act: How exclusions may undermine elimination
The United States is currently at an inflection point in Hepatitis C virus (HCV) response. We have the tools for rapid and accurate diagnosis, safe and effective cure, and prevention. These tools are only as useful as access to them can be, which is why the Cure Hepatitis C Act…
June 4, 2026
Message from TAG Executive Director Mark Harrington: 45 Years Later, We Cannot Afford Inaction
Forty-five years ago the Centers for Disease Control and Prevention (CDC) published a brief report describing five cases of a rare pneumonia among young gay men in Los Angeles. The report occupied just a few paragraphs in the Morbidity and Mortality Weekly Report (MMWR). No one reading it could have…
May 15, 2026
But…I’m a TB Activist? Perspectives from a Health Advocate on the Ground from the World Bank & International Monetary Fund Spring Meetings
The collapse of global health aid in 2025 revealed the fragility of health financing. Despite successes against TB and HIV in recent years, health aid has not generated sustainable, country-led financing for health. Now, governments are scrambling to fill funding gaps to provide life-saving care.
May 15, 2026
Financing Health Equity
The Promise and Potential of Economic Reforms for Health The collapse of global health aid in 2025 revealed the fragility of health financing. Despite successes against TB and HIV in recent years, health aid from bilateral and multilateral donors has not generated sustainable, country-led financing for health. Now, governments are…
April 23, 2026
The Path Forward: TAG’s Vision for HIV, TB, and Hepatitis C
TAG’s leadership and staff broke down the latest in HIV, TB, and hepatitis C research and advocacy. See where the work stands and where it’s headed.
April 3, 2026
Near Point-of-Care TB Tests: What Communities Need to Know and Advocate for in Global Fund Grant Cycle 8
TB testing is getting faster, cheaper, and more accessible and advocates have a critical window to act. Treatment Action Group’s new factsheet breaks down WHO-recommended near point-of-care TB tests and shows how communities can use Global Fund Grant Cycle 8 to finance their rollout. With an estimated 2.7 million people…